GENX Generix Group SA

Generix Group - Third Quarter Revenue 2020 / 2021: +2,4% at constant exchange rates

Generix Group - Third Quarter Revenue 2020 / 2021: +2,4% at constant exchange rates

FINANCIAL PRESS RELEASE

Paris, January 27, 2021

 

Revenue for Q3 2020/2021: +2,4% at constant exchange rates

Q3 2020/2021 new SaaS contracts: +35%

Confirmation of financial objectives for the fiscal period

Generix Group, a global provider of collaborative SaaS Software solutions for the Supply Chain, industrial, and retail ecosystems, issued today its revenues for the third quarter of its 2020/2021 fiscal year.

Q3 revenue stable at current exchange rates (+2,4% at constant exchange rates)

 Quarter ended

December 31
Change9 months ended December 31Change
Unaudited (K€)2020201920202019
SaaS8 3758 1643%24 07124 417-1%
Maintenance4 5124 849-7%13 48914 514-7%
Licenses9741 070-9%2 8342 8001%
Software revenues13 86114 083-2%40 39441 731-3%
Consulting Services6 8756 7332%18 44218 945-3%
Revenues20 73620 8160%58 83660 676-3%



*Reclassification of €210K over the quarter and €690K over 9 months, as Consulting and Services revenue, concerning services previously accounted for as Maintenance revenue. After reprocessing this reclassification, Maintenance revenue showed a slight drop (-3% for Q3 and -2% in YTD), primarily as a result of the temporary suspension of contracts during the lockdown period. Consulting and Services revenue, which is by nature more vulnerable in the current context, showed a -1% slight drop over Q3 and a -6% drop in YTD.

During this quarter, at the heart of the second wave of Covid-19 and the associated government restrictions (lockdown, curfew), Generix Group's activity amounted to €20.7 million, almost stable compared to the same period last year and up 8.1% compared to Q2 2020/2021. Quarter after quarter, Generix Group illustrates the resilience of its model and confirms the trajectory of a return to normative growth levels. At constant exchange rates, quarterly revenues amounted to €21.3 million, up 2.4% compared with the same quarter last year.

This quarter also marks the return to revenue growth in SaaS activities, which grew by +3% at current exchange rates, thanks to a significant improvement in overconsumption compared with previous quarters.

Over 9 months, Group revenues were €58.8 million (-3%) at current exchange rates, and €60 million, a slight decrease of 1% at constant exchange rates.

Q3 new SaaS contracts: €1,35 million (+35%)

 Quarter ended December 31Var. Q3 2020 vs Q3 20199 months ended December 31Var. 2020 vs 2019
Unaudited (K€)2020201920202019
New SaaS contract signing (ACV*)1 3491 00235%2 5302 3617%



*New contracts signed expressed in ACV (Annual Contract Value), emphasize the average annual complementary revenue to be generated after implementing the contracts in question.

In addition to the resumption of growth in the SaaS business, the past quarter was also marked by a return to a sustained pace of new SaaS contract signatures, with strong growth of 35% over the quarter. This commercial dynamic has largely offset the temporary drop in signatures in the first half year: overall, SaaS signatures are up 7% over 9 months.

Among these new signatures, it should be noted:

- A migration contract for a major player in specialized retail, which has chosen to switch the management of its warehouses and transport from a perpetual license model (On Premise) to a SaaS model;

- A contract with a new customer on the Iberian Peninsula, a banking player that has chosen the Generix Supply Chain Hub platform to manage its exchange flows and the dematerialization of its invoices. 

These contracts confirm Generix Group's ability to respond to strategic customer needs and win the trust of major players.

Confirmation of financial objectives for the fiscal period

Generix Group anticipates a sustained pace of new SaaS contract signings over the coming quarters, which should enable a return to normative growth as of the 2021/2022 financial year, after a slight decline in the 2020/2021 financial year.

Profitability trends for the 2020/2021 financial year should be in line with those observed in the first half year, with a controlled decline in EBITDA margin excluding the impact of the research and development effort.

With a sound and solid financial structure, a resilient business model, and a robust customer portfolio, the Group is confident for the future. As announced, it intends to continue its strategic investments in R&D to benefit from the potential of the supply chain and digitalization markets in which it already operates successfully.

Supplemental and non-IFRS Financial Information

Supplemental non-IFRS information (above-mentioned as EBITDA) presented in this press release is subject to inherent limitations. It is not based on any comprehensive set of accounting rules or principles and should not be considered as a substitute for IFRS measurements. Also, the Company’s supplemental non-IFRS financial information may not be comparable to similarly titled non-IFRS measures used by other companies.

Next financial press release: April 28, 2021 after the market closes

Revenues for the financial year 2020/2021

About Generix Group

Generix Group is a Collaborative Supply Chain expert present in 60 countries, thanks to its subsidiaries and network of partners. More than 6,000 companies around the world use its SaaS solutions. The group’s 750 employees provide daily support for such customers as Carrefour, Danone, FM Logistic, Fnac-Darty, Essilor, Ferrero and Geodis in the digital transformation of their Supply Chain.

Its collaborative platform, Generix Supply Chain Hub, helps companies to keep the promises they make to their customers. It combines the capabilities to execute physical flows, digitalize information flows, manage collaborative processes and connect companies to all their partners, in real time.

Generix Supply Chain Hub is aimed at all players in the Supply Chain: manufacturers, third- and fourth-party logistics providers (3PL/4PL) and retailers. 

Founded in France in 1990, the company is listed on the Eurolist market of Euronext Paris, compartment C (ISIN: FR0010501692). To learn more:  

Financial Communication Contacts:

Generix Group—Ludovic Luzza—Chief Financial Officer—Tel.: +33 (0)1 77 45 42 80 –

CIC Market Solutions—Stéphanie Stahr—Tel.: +33 (0)1 53 48 80 57—

Attachment



EN
27/01/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Generix Group SA

 PRESS RELEASE

Generix Group : Aïda Collette-Sène nommée Présidente du directoire de ...

Generix Group : Aïda Collette-Sène nommée Présidente du directoire de Generix Group                Communiqué de presse      Le 15 septembre 2022 Aïda Collette-Sène nommée Présidente du directoire de Generix Group Generix Group annonce que le Conseil de Surveillance a nommé Madame Aïda Collette-Sène aux fonctions de Présidente du Directoire, à compter du 1er septembre 2022. Directrice Générale de Generix Group depuis avril 2018, après un parcours de près de 20 ans au sein du groupe CGI, elle prend la succession de Monsieur Jean-Charles Deconninck qui dirigeait la société depui...

 PRESS RELEASE

Generix Group - Information relative au nombre total de droits de vote...

Generix Group - Information relative au nombre total de droits de vote et d’actions au 31 août 2022 COMMUNIQUE FINANCIER Lesquin, le 9 Septembre 2022 Generix Group - Information relative au nombre total de droits de vote et d’actions Prévue par l’article L. 233-8 II du Code de Commerce et l’article 223-16 du règlement général de l’Autorité des Marchés Financiers DateNombre d’actionsNombre de droits de vote théoriques des actions31/08/202222 703 86323 198 086 FR À propos de Generix Group  Generix Group est un expert de la Supply Chain Collaborative présent dans plus de 60 pays, grâce à...

 PRESS RELEASE

Résultat de l’Offre Publique d’Achat Simplifiée

Résultat de l’Offre Publique d’Achat Simplifiée Generix Group          Communiqué de presse          Le 25 août 2022 Résultat de l’Offre Publique d’Achat Simplifiée Generix Group et New Gen Holding annoncent que le 24 août 2022, l’Autorité des marchés financiers a publié les résultats de l’offre publique d’achat simplifiée clôturée le 19 août 2022 et visant la totalité des actions Generix Group non détenues par New Gen Holding. A l’issue de l’offre publique d’achat simplifiée, l’Initiateur New Gen Holding a acquis 6 589 041 actions dans le cadre de la procédure de semi-centralisation. ...

 PRESS RELEASE

Generix Group - Information relative au nombre total de droits de vote...

Generix Group - Information relative au nombre total de droits de vote et d’actions au 31 juillet 2022 COMMUNIQUE FINANCIER Lesquin, le 8 Août 2022 Generix Group - Information relative au nombre total de droits de vote et d’actions Prévue par l’article L. 233-8 II du Code de Commerce et l’article 223-16 du règlement général de l’Autorité des Marchés Financiers DateNombre d’actionsNombre de droits de vote théoriques des actions31/07/202222 703 86323 756 862 FR À propos de Generix Group  Generix Group est un expert de la Supply Chain Collaborative présent dans plus de 60 pays, grâce à s...

 PRESS RELEASE

Generix Group - Bilan semestriel du contrat de liquidité GENERIX contr...

Generix Group - Bilan semestriel du contrat de liquidité GENERIX contracté avec NATIXIS ODDO BHF COMMUNIQUE FINANCIER Lesquin, le 3 Aout 2022 Generix Group - Bilan semestriel du contrat de liquidité GENERIX contracté avec NATIXIS ODDO BHF Au titre du contrat de liquidité confié à NATIXIS ODDO BHF portant sur les actions de la société GENERIX, à la date du 30 Juin 2022, les moyens suivants figuraient au compte de liquidité : 27 099 titres GENERIX50 430.95€         Lors du dernier bilan semestriel, à la date du 31 Décembre 2021, les moyens suivants figuraient au compte de liquidité :   ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch